Peldesine dihydrochloride is used in the research of cutaneous T-cell lymphoma, psoriasis, and HIV infection; it acts as a potent, competitive, reversible, and orally active inhibitor of purine nucleoside phosphorylase (PNP) and as an inhibitor of T-cell proliferation.